Mersen (0Q6Q)
London Exchange · UK · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 35.83 |
|---|---|
| 52-week range | 20.43 – 45.32 |
| Return, 1 month / 3 months | −12.6% / −2.0% |
| Return, 1 year / 3 years | +35.7% / +16.8% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 36 |
| Volatility (1 year) | 43.8% |
| Worst drawdown (1 year) | -26.7% |
| Average daily value traded | 0.33M EUR |
| Dividend yield | 2.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Mersen is a French industrial group that supplies electrical protection and advanced materials. It makes fuses, surge protection devices and other components that safeguard electrical installations, and it produces graphite-based materials and equipment used in high-temperature and corrosive industrial processes. Its customers include manufacturers in energy, electronics, chemicals and transport, and the company is based in France with operations across Europe, North America and Asia.
On this site Mersen appears as a stock on the London Exchange (UK), code 0Q6Q, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Mersen (0Q6Q) trades on the London Exchange in UK. It last closed at EUR 35.83 on 22 October 2026.
Its price-based Market X-Ray is 58 out of 100 (a fair price profile), ranking 1,527 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 35.7% and over the last three months it fell 2.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 69 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 7.2% | ||
| From 52-week high | -19.9% | ||
| Momentum | 75 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | -2.0% | ||
| 6-month return | 32.7% | ||
| 12-month return, skipping the last month | 55.2% | ||
| Stability (higher is calmer) | 46 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 43.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -26.7% | ||
| Liquidity | 42 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.33M EUR | ||
| Zero-volume days | 1.7% | ||
| Income | 42 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.5% | ||
| Years with dividends | 5 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −10.8% |
|---|---|
| 1 month | −12.6% |
| 3 months | −2.0% |
| 6 months | +32.7% |
| 1 year | +35.7% |
| 3 years | +16.8% |
| 5 years | +40.5% |
Signals
| 50-day / 200-day average | 39.25 / 33.44 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.47 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 Jul 2026 | EUR 0.9000 |
| 7 Jul 2025 | EUR 0.9000 |
| 2 Jul 2024 | EUR 1.2500 |
| 4 Jul 2023 | EUR 1.2500 |
| 5 Jul 2022 | EUR 1.0000 |
| 6 Jul 2021 | EUR 0.6500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.